<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2077-2161</journal-id>
<journal-title><![CDATA[Ajayu Órgano de Difusión Científica del Departamento de Psicología UCBSP]]></journal-title>
<abbrev-journal-title><![CDATA[Ajayu]]></abbrev-journal-title>
<issn>2077-2161</issn>
<publisher>
<publisher-name><![CDATA[Universidad Cátolica Boliviana "San Pablo"]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2077-21612022000100022</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[PERFIL NEUROPSICOLÓGICO DE CONSUMIDORES DE METANFETAMINAS, CON BASE EN LA REGULACIÓN EMOCIONAL Y RASGOS DE PERSONALIDAD]]></article-title>
<article-title xml:lang="en"><![CDATA[NEUROPSYCHOLOGICAL PROFILE OF METHAMPHETAMINE USERS, BASED ON EMOTIONAL REGULATION AND PERSONALITY TRAITS]]></article-title>
<article-title xml:lang="pt"><![CDATA[PERFIL NEUROPSICOLÓGICO DE USUÁRIOS DE METANFETAMINA, BASEADO NA REGULAÇÃO EMOCIONAL E TRAÇOS DE PERSONALIDADE.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Da Silva Rodrigues]]></surname>
<given-names><![CDATA[Charles Ysaacc]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carvalho de Figueiredo]]></surname>
<given-names><![CDATA[Paula Alexandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez Troncoso]]></surname>
<given-names><![CDATA[Omar Guadalupe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Saldaña Guzman]]></surname>
<given-names><![CDATA[Alan Sealtiel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pombo Marques]]></surname>
<given-names><![CDATA[Paulo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gómez Calderón]]></surname>
<given-names><![CDATA[José Félix]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Guanajuato  ]]></institution>
<addr-line><![CDATA[Guanajuato ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,CESUN Universidad  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Centro de Integración Juvenil León  ]]></institution>
<addr-line><![CDATA[Guanajuato ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2022</year>
</pub-date>
<volume>20</volume>
<numero>1</numero>
<fpage>22</fpage>
<lpage>43</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S2077-21612022000100022&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S2077-21612022000100022&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S2077-21612022000100022&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN El consumo compulsivo y continuo de metanfetaminas puede causar un cierto desorden funcional de los procesos neuropsicológicos, sobre todo, de las funciones ejecutivas, lenguaje, memoria, orientación, concentración y atención. El objetivo de esto trabajo fue verificar la existencia de manifestaciones cognitivamente significativas, entre grupos, y la influencia de los estados emocionales y de los rasgos de personalidad en esos posibles cambios. El método fue un estudio descriptivo y comparativo, con un enfoque cuantitativo, con la participación de 87 personas, divididas homogéneamente en tres grupos: grupo de usuarios (G1), grupo de usuarios en abstinencia (G2), y grupo de no usuarios (G3); evaluados en el ámbito neuropsicológico (NEUROPSI), y dimensiones de: personalidad (NEO-FFI) y regulación emocional (DASS-21). Se verificaron alteraciones estadísticamente significativas entre consumidores y abstemios, cuando comparados con el grupo de control, así como, entre los mismos grupos de consumidores y abstemios. Y una influencia significativa en el procesamiento cognitivo, debido a las manifestaciones emocionales y rasgos de personalidad. Entre otros hallazgos, se puede referir que altos niveles de estrés y ansiedad afectan al manejo de las funciones ejecutivas en un 30%.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Compulsive and continuous use of methamphetamine can cause a certain functional disorder of neuropsychological processes, especially, of the executive functions, language, memory, orientation, concentration and attention. The aim of the investigation has been to verify the existence of cognitively significant manifestations, between groups, and the influence of emotional states and personality traits in these possible changes. Regarding its method, this has been descriptive and comparative study, with a quantitative approach, with the participation of 87 people, evenly divided into three groups: user group (G1), group of users in abstinence (G2), and non-user group (G3); evaluated in the neuropsychological field (NEUROPSI), and dimensions of: personality (NEO-FFI) and emotional regulation (DASS-21). Statistically significant alterations were verified between consumers and abstainers, when compared with the control group, as well as, between the same groups of consumers and abstainers. And a significant influence on cognitive processing, due to emotional manifestations and personality traits. Among other findings, it can be mentioned that high levels of stress and anxiety affect the management of executive functions by 30%.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO O uso compulsivo e contínuo de metanfetaminas pode causar certo distúrbio funcional dos processos neuropsicológicos, principalmente, das funções executivas, linguagem, memória, orientação, concentração e atenção. O objetivo da investigação foi verificar a existência de manifestações cognitivamente significativas, entre grupos, e a influência de estados emocionais e traços de personalidade nessas possíveis mudanças. Quanto ao método, trata-se de um estudo descritivo e comparativo, com abordagem quantitativa, com a participação de 87 pessoas, divididas igualmente em três grupos: grupo de usuários (G1), grupo de usuários em abstinência (G2) e grupo de não usuários. (G3); avaliada na área neuropsicológica (NEUROPSI), e dimensões: personalidade (NEO-FFI) e regulação emocional (DASS-21). Foram verificadas alterações estatisticamente significativas entre consumidores e abstêmios, quando comparados com o grupo controle, bem como, entre os mesmos grupos de consumidores e abstêmios. E uma influência significativa no processamento cognitivo, devido às manifestações emocionais e traços de personalidade. Entre outros achados, pode-se citar que altos níveis de estresse e ansiedade afetam o gerenciamento das funções executivas em 30%.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[neuropsicología]]></kwd>
<kwd lng="es"><![CDATA[personalidad]]></kwd>
<kwd lng="es"><![CDATA[emoción]]></kwd>
<kwd lng="es"><![CDATA[metanfetamina]]></kwd>
<kwd lng="en"><![CDATA[neuropsychology]]></kwd>
<kwd lng="en"><![CDATA[personality]]></kwd>
<kwd lng="en"><![CDATA[emotion]]></kwd>
<kwd lng="en"><![CDATA[methamphetamine]]></kwd>
<kwd lng="pt"><![CDATA[neuropsicologia]]></kwd>
<kwd lng="pt"><![CDATA[personalidade]]></kwd>
<kwd lng="pt"><![CDATA[emoção]]></kwd>
<kwd lng="pt"><![CDATA[metanfetamina]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrero]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Abanades]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Farré]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metanfetaminas]]></article-title>
<source><![CDATA[Atención Primaria]]></source>
<year>2005</year>
<volume>35</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>445-502</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bagheri]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mokri]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Khosravi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Kabir]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of Abstinence on Depression, Anxiety, and Quality of Life in Chronic Methamphetamine Users in a Therapeutic Community]]></article-title>
<source><![CDATA[International journal of high risk behaviors &amp; addiction]]></source>
<year>2015</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-5</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Courtney]]></surname>
<given-names><![CDATA[K. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Ray]]></surname>
<given-names><![CDATA[L. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature]]></article-title>
<source><![CDATA[Drug and alcohol dependence]]></source>
<year>2014</year>
<volume>143</volume>
<page-range>11-21</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cruickshank]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Dyer]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A review of the clinical pharmacology of methamphetamine]]></article-title>
<source><![CDATA[Addiction]]></source>
<year>2009</year>
<volume>104</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1085-99</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Da Silva]]></surname>
<given-names><![CDATA[C. Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[P. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pombo]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[J. F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alteraciones neuropsicológicas asociadas al consumo de la Dextro-metil-anfetamina en adolescentes mexicanos]]></article-title>
<source><![CDATA[Revista Internacional de Investigación en Adicciones]]></source>
<year>2019</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15-22</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faraone]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities]]></article-title>
<source><![CDATA[Neuroscience Biobehavioral]]></source>
<year>2018</year>
<volume>87</volume>
<page-range>255-70</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furlong]]></surname>
<given-names><![CDATA[T. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Corbit]]></surname>
<given-names><![CDATA[L. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[R. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Balleine]]></surname>
<given-names><![CDATA[B. W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Methamphetamine promotes habitual action and alters the density of striatal glutamate receptor and vesicular proteins in dorsal striatum]]></article-title>
<source><![CDATA[Addiction Biology]]></source>
<year>2017</year>
<volume>23</volume>
<page-range>857-67</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gurrola Peña]]></surname>
<given-names><![CDATA[G. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Balcázar Nava]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Bonilla Muños]]></surname>
<given-names><![CDATA[M. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Virseda Heras]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estructura factorial y consistencia interna de la escala de Depresión Ansiedad y Estrés (DASS-21) en una muestra no clínica]]></article-title>
<source><![CDATA[Psicología y Ciencia Social]]></source>
<year>2006</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>3-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Janetsian]]></surname>
<given-names><![CDATA[S. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Linsenbardt]]></surname>
<given-names><![CDATA[D. N.]]></given-names>
</name>
<name>
<surname><![CDATA[Lapish]]></surname>
<given-names><![CDATA[C. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Memory impairment and alterations in prefrontal cortex gamma band activity following methamphetamine sensitization]]></article-title>
<source><![CDATA[Psychopharmacology]]></source>
<year>2015</year>
<volume>232</volume>
<page-range>2083-95</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Alicata]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Cloak]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuropsychological deficits in adolescent methamphetamine abusers]]></article-title>
<source><![CDATA[Psychopharmacology]]></source>
<year>2010</year>
<volume>212</volume>
<page-range>243-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lovibond]]></surname>
<given-names><![CDATA[S. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Lovibond]]></surname>
<given-names><![CDATA[P. F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Manual for the Depression Anxiety Stress Scales]]></source>
<year>1995</year>
<edition>2</edition>
<publisher-loc><![CDATA[Sydney ]]></publisher-loc>
<publisher-name><![CDATA[Psychology Foundation of Australia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Milhorn]]></surname>
<given-names><![CDATA[H. T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Substance Use Disorders. A Guide for the Primary Care Provider]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Switzerland ]]></publisher-loc>
<publisher-name><![CDATA[Springer International Publishing AG]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morais]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pita]]></surname>
<given-names><![CDATA[I. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Fontes-Ribeiro]]></surname>
<given-names><![CDATA[C. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[F. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The neurobiological mechanisms of physical exercise in methamphetamine addiction]]></article-title>
<source><![CDATA[CNS neuroscience &amp; therapeutics]]></source>
<year>2018</year>
<volume>24</volume>
<page-range>85-97</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moratalla]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Khairnar]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Simola]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Granado]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[García-Montes]]></surname>
<given-names><![CDATA[J. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Porceddu]]></surname>
<given-names><![CDATA[P. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Tizabi]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Morelli]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms]]></article-title>
<source><![CDATA[Progress in Neurobiology]]></source>
<year>2017</year>
<volume>155</volume>
<page-range>149-70</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meda-Lara]]></surname>
<given-names><![CDATA[R. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno-Jiménez]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[L. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Palomera Chávez]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Mariscal de Santiago]]></surname>
<given-names><![CDATA[M. V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validez factorial del NEO-FFI en una muestra mexicana: Propuesta de una versión reducida]]></article-title>
<source><![CDATA[Revista Mexicana de Psicología]]></source>
<year>2015</year>
<volume>32</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>57-67</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ostrosky]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Ardila]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Roselli]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuropsi: Evaluación Neuropsicológica Breve en español]]></source>
<year>2013</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Manual Moderno]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ostrosky]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[M. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Matute]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Rosselli]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ardila]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pineda]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuropsi: Atención y Memoria]]></source>
<year>2019</year>
<edition>3</edition>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Manual Moderno]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Owens]]></surname>
<given-names><![CDATA[C. V.]]></given-names>
</name>
<name>
<surname><![CDATA[Mason]]></surname>
<given-names><![CDATA[M. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Marr]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Remediation of Manufactured Methamphetamine in Clandestine Laboratories. A Literature Review]]></article-title>
<source><![CDATA[Journal of chemical health &amp; safety]]></source>
<year>2017</year>
<volume>24</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>23-37</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pal]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Mendelson]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Clavier]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Baggott]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Coyle]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Galloway]]></surname>
<given-names><![CDATA[G. P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and Testing of a Smartphone-Based Cognitive/Neuropsychological Evaluation System for Substance Abusers]]></article-title>
<source><![CDATA[Journal of Psychoactive Drugs]]></source>
<year>2016</year>
<volume>48</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>288-94</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piñón]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Lage]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Carrera]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Cerqueiro]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Bobadilla]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Spuch]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Otero]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perfil neuropsicológico y sintomatología psicopatológica de pacientes con trastornos relacionados con sustancias a tratamiento en una unidad de día]]></article-title>
<source><![CDATA[Health and Addictions]]></source>
<year>2019</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>70-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prakash]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Tangalakis]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Antonipillai]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Stojanovska]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Nurgali]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Apostolopoulos]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Methamphetamine: Effects on the brain, gut and immune system]]></article-title>
<source><![CDATA[Pharmacological Research]]></source>
<year>2017</year>
<volume>120</volume>
<page-range>60-7</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Román]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Santibáñez]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Vinet]]></surname>
<given-names><![CDATA[E. V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of the Depression Anxiety Stress Scales (DASS-21) as Screening Tests in Clinical Youngsters]]></article-title>
<source><![CDATA[Acta de Investigación Psicológica]]></source>
<year>2016</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>2325-36</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sheridan]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Coggan]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Wheeler]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[McMillan]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Injury associated with methamphetamine use: A review of the literature]]></article-title>
<source><![CDATA[Harm Reduction Journal]]></source>
<year>2006</year>
<volume>3</volume>
<numero>14</numero>
<issue>14</issue>
<page-range>1-18</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Woods]]></surname>
<given-names><![CDATA[S. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Matt]]></surname>
<given-names><![CDATA[G. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Meyer]]></surname>
<given-names><![CDATA[R. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Heaton]]></surname>
<given-names><![CDATA[R. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Atkinson]]></surname>
<given-names><![CDATA[J. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Grant]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neurocognitive effects of methamphetamine: a critical review and meta-analysis]]></article-title>
<source><![CDATA[Neuropsychology Review]]></source>
<year>2007</year>
<volume>17</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>275-97</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shukla]]></surname>
<given-names><![CDATA[R. K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Methamphetamine: A Love Story]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Oakland, California ]]></publisher-loc>
<publisher-name><![CDATA[University of California Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Somkuwar]]></surname>
<given-names><![CDATA[S. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Staples]]></surname>
<given-names><![CDATA[M. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Fannon]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Ghofranian]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Mandyam]]></surname>
<given-names><![CDATA[C. D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluating Exercise as a Therapeutic Intervention for Methamphetamine Addiction-Like Behavior]]></article-title>
<source><![CDATA[Brain plasticity]]></source>
<year>2015</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>63-81</page-range><publisher-loc><![CDATA[Amsterdam, Netherlands ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stock]]></surname>
<given-names><![CDATA[A.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Rädle]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Beste]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Methamphetamine-associated difficulties in cognitive control allocation may normalize after prolonged abstinence]]></article-title>
<source><![CDATA[Prog Neuropsychopharmacol. Biological Psychiatry]]></source>
<year>2018</year>
<volume>88</volume>
<page-range>41-52</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thanos]]></surname>
<given-names><![CDATA[P. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Delis]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Ananth]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Chachati]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Rocco]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Masad]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Muniz]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Grant]]></surname>
<given-names><![CDATA[S.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Gold]]></surname>
<given-names><![CDATA[M.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Cadet]]></surname>
<given-names><![CDATA[J.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Volkow]]></surname>
<given-names><![CDATA[N. D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic Methamphetamine Effects on Brain Structure and Function in Rats]]></article-title>
<source><![CDATA[PloS one]]></source>
<year>2016</year>
<volume>11</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Widiger]]></surname>
<given-names><![CDATA[T. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Costa Jr.]]></surname>
<given-names><![CDATA[P. T.]]></given-names>
</name>
</person-group>
<source><![CDATA[Personality disorders and the five-factor model of personality]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Washington, DC ]]></publisher-loc>
<publisher-name><![CDATA[American Psychological Association]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
